Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy

Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy

Nimisha Sulejmani,1 Syed-Mohammed Jafri2 1Department of Pharmacy, Henry Ford Hospital, Detroit, MI, USA; 2Division of Gastroenterology, Henry Ford Hospital, Detroit, MI, USA Abstract: Chronic hepatitis C virus (HCV) infection impacts approximately 71 million people and approximately 400,000 deaths a...

Full description

Bibliographic Details
Main Authors: Sulejmani N, Jafri SM
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Hepatic Medicine: Evidence and Research
Subjects:
hepatitis c virus
grazoprevir
elbasvir
NS3
NS4
NS5A
protease inhibitors
Online Access:https://www.dovepress.com/grazoprevirelbasvir-for-the-treatment-of-adults-with-chronic-hepatitis-peer-reviewed-article-HMER

Internet

https://www.dovepress.com/grazoprevirelbasvir-for-the-treatment-of-adults-with-chronic-hepatitis-peer-reviewed-article-HMER

Similar Items